Genitourinary Cancer News

The BCG vaccine appeared associated with a significantly lower rate of and risk for Alzheimer’s disease and related dementias among patients with nonmuscle-invasive bladder cancer, according to data published in JAMA Network Open.

Primary endpoints of randomized clinical trials for cancer therapies frequently change after trial initiation, according to findings published in JAMA Network Open.

In this video, Brad McGregor, MD, clinical director of Dana-Farber Cancer Institute's Lank Center for Genitourinary Cancer, discussed the rise of hypoxia-inducible factor-2 inhibitors to treat renal cell carcinoma.

In this video, Brad McGregor, MD, discussed data regarding adjuvant therapies for renal cell carcinoma presented at the American Urological Association Annual Meeting.

Cancer death rates decreased overall across congressional districts in the United States over the past 25 years, according to a study published in Cancer.

Patients with primary renal cell carcinoma who quit smoking after diagnosis had a 50% lower risk for death than those who continued to smoke, according to study results published in Journal of Clinical Oncology.

Survivors of testicular cancer often have undetected risk factors for cardiovascular disease that can lead to worse quality of life, according to data published in Journal of Clinical Oncology.

Telemedicine garnered higher satisfaction ratings than in-person visits among patients with cancer in terms of access and care provider concern, according to a study published in Journal of the National Comprehensive Cancer Network.

The combination of belzutifan and cabozantinib showed promising antitumor activity among patients with previously treated metastatic clear cell renal cell carcinoma, according to data published in The Lancet Oncology.

Obesity-related cancer mortality rates tended to be higher in counties with limited access to grocery stores or greater access to fast food, according to data published in JAMA Oncology.